Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem, Craig M. Crews
Cell (2020) Vol. 181, Iss. 1, pp. 102-114
Open Access | Times Cited: 771

Showing 1-25 of 771 citing articles:

PROTAC targeted protein degraders: the past is prologue
Miklós Békés, David R. Langley, Craig M. Crews
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 181-200
Open Access | Times Cited: 1824
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 839-861
Closed Access | Times Cited: 569
The mechanisms and roles of selective autophagy in mammals
Jose Norberto S. Vargas, Maho Hamasaki, Tsuyoshi Kawabata, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 3, pp. 167-185
Closed Access | Times Cited: 547
Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 374
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha, Craig M. Crews
Cell chemical biology (2020) Vol. 27, Iss. 8, pp. 998-1014
Open Access | Times Cited: 334
Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
Michael J. Bond, Ling Chu, Dhanusha A. Nalawansha, et al.
ACS Central Science (2020) Vol. 6, Iss. 8, pp. 1367-1375
Open Access | Times Cited: 325
Cellular senescence: a key therapeutic target in aging and diseases
Lei Zhang, Louise E. Pitcher, Matthew J. Yousefzadeh, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 309
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Lei Zhang, Louise E. Pitcher, Vaishali Prahalad, et al.
FEBS Journal (2022) Vol. 290, Iss. 5, pp. 1362-1383
Open Access | Times Cited: 295
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman, et al.
Cell (2020) Vol. 183, Iss. 6, pp. 1714-1731.e10
Open Access | Times Cited: 282
Therapeutic strategies targeting FOXO transcription factors
Giampaolo Calissi, Eric W.‐F. Lam, Wolfgang Link
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 21-38
Closed Access | Times Cited: 246
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Sohum Mehta, Jin Zhang
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 239-252
Open Access | Times Cited: 246
Deubiquitinase-targeting chimeras for targeted protein stabilization
Nathaniel J. Henning, Lydia Boike, Jessica N. Spradlin, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 4, pp. 412-421
Open Access | Times Cited: 211
The Mediator complex as a master regulator of transcription by RNA polymerase II
William F. Richter, Shraddha Nayak, Janet Iwasa, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 11, pp. 732-749
Open Access | Times Cited: 191
Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
Che-Wei Chang, Qiang Shao, Lennart Mucke
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 189
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 188
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Xinyi Li, Wenchen Pu, Qingquan Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 185
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan, Hong Bu, Jinpei Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11368-11396
Closed Access | Times Cited: 175
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Wenhao Guo, Xiaoli Qi, Xin Yu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 163
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond, Craig M. Crews
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 725-742
Open Access | Times Cited: 161
Emerging strategies to target RAS signaling in human cancer therapy
Kun Chen, Yalei Zhang, Ling Qian, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 160
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
Aleša Bricelj, Christian Steinebach, Robert D. Kuchta, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 158
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu, Craig M. Crews
ChemBioChem (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 158
Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications
Nathaniel J. Henning, Andrew G. Manford, Jessica N. Spradlin, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 2, pp. 701-708
Open Access | Times Cited: 157
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 149
Page 1 - Next Page

Scroll to top